Contact this ipamorelin digest

Editorial correspondence

Legit Ipamorelin is an editorial digest of the published ipamorelin literature. We welcome correspondence on two things: corrections to anything we have summarized inaccurately, and suggestions of peer-reviewed studies we should add. If you can point to a study — by DOI, PubMed ID, or trial number — that sharpens or corrects the record, we want to see it.

We cannot answer medical questions, recommend doses, comment on personal protocols, or advise on whether anyone should use ipamorelin or any combination. Those are clinical matters and this is not a clinic. We also do not sell, source, or broker any product, and we cannot help with purchasing or suppliers.

Send a message

Use the form below to reach the editorial desk. A name, an email address, and your message are all we ask. For corrections and source suggestions, including the citation details (DOI, PubMed ID, or trial registry number) helps us act on your note quickly. We read everything sent through the form, though we cannot guarantee an individual reply.